American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines
Clicks: 268
ID: 116044
1994
CSFs are recommended in some situations, eg, to reduce the likelihood of febrile neutropenia when the expected incidence is > or = 40%; after documented febrile neutropenia in a prior chemotherapy cycle to avoid infectious complications and maintain dose-intensity in subsequent treatment cycles w …
| Reference Key |
1994journalamerican
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ; |
| Journal | journal of clinical oncology : official journal of the american society of clinical oncology |
| Year | 1994 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
clinical trials as topic
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
Child
Comparative Study
Medical*
United States
practice guideline
guideline
societies
drug-related side effects and adverse reactions
neoplasms / therapy
pmid:7964965
doi:10.1200/jco.1994.12.11.2471
colony-stimulating factors / adverse effects
colony-stimulating factors / economics
colony-stimulating factors / therapeutic use*
medical oncology*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.